Most recent update: Sunday, April 29, 2018 - 14:56

You are here

Product offering

Acelity offers new gelling fibre advanced wound dressing

Acelity’s Biosorb gelling fibre dressing is now available in the US and has been awarded the CE Mark in Europe, where it will be available in the coming months. The Biosorb dressing is a wound dressing that forms a gel when it comes into contact with an exuding wound. According to the company, this dressing offers increased absorbency and the ability to hold its shape, allowing for intact removal, which is designed to make dressing changes less painful for patients.

Biosorb gelling fibre dressing

Acelity’s Biosorb gelling fibre dressing is now available in the US and has been awarded the CE Mark in Europe, where it will be available in the coming months. The Biosorb dressing is a wound dressing that forms a gel when it comes into contact with an exuding wound. According to the company, this dressing offers increased absorbency and the ability to hold its shape, allowing for intact removal, which is designed to make dressing changes less painful for patients. The dressing can be used for a variety of exuding wounds including leg ulcers, pressure ulcers, diabetic foot ulcers, surgical wounds that exude fluid, partial thickness burns, traumatic and oncology wounds.

“The Biosorb Dressing provides an important treatment option for my patients because it leverages gelling fibre technology to help create an optimal environment for wound healing while protecting the wound edge with its increased absorbency, thus supporting the healing process,” said Professor Keith G Harding, dean of clinical innovation, Cardiff University, and medical director, Welsh Wound Innovation Centre. “But perhaps even more importantly, the unique construction is designed to minimize pain for patients, a common problem that is critical to address as part of treatment, particularly given that some wounds can last for months or years and require frequent dressing changes.”

Biosorb gelling fibre dressing comprises CMC (carboxymethylcellulose) fibres which allow the dressing to absorb many times its own weight in fluid, protecting the wound edge and surrounding skin. Furthermore, its cellulose fibres reinforce the dressing, allowing it to remain strong and intact when wet. The product is designed to provide ease of application for the clinician, as well as pain-free removal, to create a more comfortable option for patients compared to many other fibre dressings. Biosorb gelling fibre dressing is currently available in the non-silver format (non-antimicrobial), with the silver version (anti-microbial) expected to follow early in 2017.

“The addition of gelling fibre delivers on an important component of our business strategy in that Acelity now has a complete range of advanced wound dressings that will address a full spectrum of patient needs,” said Joe Woody, president and CEO of Acelity. “These dressings, combined with our negative pressure wound technologies form the most comprehensive wound care portfolio offering clinicians around the world healing solutions no matter the acuity or care setting.

Chronic and surgical wounds affect more than 10.5 million people in the US and Europe and constantly require treatment and attention. The Biosorb Dressing is a highly absorbent fibre dressing - demonstrated in vitro to have greater absorbency than other leading gelling fibres - designed to efficiently manage fluid levels in a variety of wound types. Fibre dressings help keep the wound moist while absorbing excess exudate to limit the chance of maceration, a softening or separation of skin and tissue due to moisture exposure, which can be detrimental to the healing process if left unmanaged.